BirchBioMed Inc. (BRBM)

BirchBioMed will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

BirchBioMed Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Income	-3.13	-3.46	-0.85
Net Income	-4.24	-4.55	-0.89

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Cash & Investments	3.19	3.43	0.82
Total Debt	0.12	9.44	3.47
Net Cash (Debt)	3.07	-6.01	-2.65
Net Cash Growth	-	-	-

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Operating Cash Flow	-2.13	-2.2	-0.79
Free Cash Flow	-2.13	-2.2	-0.79
Free Cash Flow Growth	-	-	-